Compliance in Healthcare Procurement in the Czech Republic: How to Avoid Criminal Liability

Healthcare procurement in the Czech Republic is heavily regulated and increasingly monitored for fraud and corruption. Hospital managers and procurement staff face serious criminal penalties, including imprisonment and substantial fines, if procurement procedures are mishandled. This article explains the key legal requirements, real-world risks you must understand, and practical steps to protect your organization from criminal liability and financial ruin.

The high-stakes reality of healthcare procurement compliance

Healthcare procurement in the Czech Republic operates within a complex legal framework designed to ensure transparency, fairness, and public accountability. However, this system carries consequences far more serious than most procurement professionals realize.

The European Public Prosecutor's Office (EPPO) and Czech National Organized Crime Agency (NCOZ) have deeply investigated systematic corruption schemes in hospitals involving hundreds of millions of crowns. These investigations have resulted in criminal charges against hospital directors, procurement managers, and officials. Some face imprisonment and personal liability that no organizational position can shield.

The legal reality is straightforward: improper healthcare procurement isn't just an administrative violation. It's a criminal matter. Under Czech criminal law, certain procurement violations cross the line from regulatory breach into criminal territory, exposing individuals to prosecution, asset seizure, and imprisonment.

The lawyers at ARROWS Law Firm regularly handle healthcare procurement disputes and have extensive experience identifying where everyday procurement decisions can inadvertently create criminal exposure. What makes this landscape particularly treacherous is that the distinction between administrative non-compliance and criminal conduct often isn't obvious to those managing day-to-day activities.

Understanding this distinction is essential because the consequences of crossing it are life-altering. Hospital directors have been arrested in their offices, and procurement managers have faced criminal investigations lasting years.

Facilities that believed they were following standard practices have discovered they were exposed to prosecution. This isn't theoretical—it has happened in major Czech hospitals, and the enforcement activity is accelerating.

The legal framework governing healthcare procurement in the Czech Republic

Healthcare procurement in the Czech Republic is governed primarily by Act No. 134/2016 Coll., on Public Procurement (the "PPA"), which implements European Union Directive 2014/24/EU. This legislation establishes the foundational principles that all healthcare facilities must follow when purchasing medical devices, pharmaceuticals, and services.

The principles underlying this framework are transparency, equal treatment, non-discrimination, and proportionality. These aren't mere suggestions; they're mandatory legal requirements with criminal consequences for violation.

The Office for the Protection of Competition (ÚOHS) serves as the primary enforcement authority, actively supervising healthcare procurement to ensure compliance with legal regulations. This agency has the power to investigate procurement procedures, impose administrative fines, and recommend cases for criminal prosecution.

Importantly, healthcare facilities cannot acquire medical equipment, pharmaceuticals, or services at their discretion—they must follow formalized procedures established by law. This requirement applies regardless of whether a hospital believes it's acting in the patient's best interest, unless specific statutory exceptions apply.

The legal framework also incorporates European standards for medical devices and pharmaceuticals. Hospitals must not use medical devices lacking proper certification, such as a missing CE mark, in accordance with the Medical Devices Act (Act No. 375/2022 Coll.) and MDR regulation.

Using uncertified medical devices exposes the contracting authority to sanctions from the State Institute for Drug Control (SÚKL) and liability for patient harm. This requirement creates a dual compliance burden: hospitals must ensure not only that procurement procedures are lawful, but that the products themselves meet European safety and quality standards.

What complicates matters significantly is that Czech healthcare procurement law doesn't operate in isolation. It intersects with European Union regulations on foreign subsidies, international sanctions enforcement, and anti-corruption standards.

ARROWS Law Firm regularly advises international clients operating in the Czech market on how EU standards interact with Czech law, and how European enforcement trends affect healthcare procurement decisions.

Financial thresholds and aggregation requirements: where hospitals make critical mistakes

One of the most frequent sources of criminal exposure in healthcare procurement involves miscalculating contract values and incorrectly aggregating purchase orders. This might seem like a technical accounting issue, but miscalculation can trigger criminal liability.

Miscalculation often facilitates illegal contract splitting—one of the most actively prosecuted offenses in healthcare procurement. The Czech PPA establishes specific financial thresholds that determine which procurement procedures must be followed.

Currently, the threshold for small-scale public contracts (VZMR) is set at CZK 3,000,000 for supplies and services, and CZK 9,000,000 for construction work. Below these thresholds, contracting authorities can conduct procurement using simplified internal procedures.

Above these thresholds, formal tender procedures under the PPA become mandatory. However—and this is where hospitals routinely encounter criminal risk—these thresholds don't operate independently for each purchase.

The law requires aggregation: if purchases are functionally, locally, and temporally linked, their values must be combined to determine the applicable threshold. For pharmaceuticals specifically, this creates significant complexity.

Medicines belonging to the same ATC group are considered "supplies of the same kind" by the ÚOHS and must be aggregated together. This means a hospital cannot purchase medication ABC in January and medication XYZ in March from different suppliers if they fall within the same ATC category.

Why does this matter? Because the Office for the Protection of Competition actively investigates hospitals that appear to be deliberately fragmenting purchases to evade the need for formal tender procedures.

Several hospitals have faced substantial fines precisely because they purchased medicines from different suppliers without conducting proper tender procedures. The ÚOHS explicitly determined that medicines from the same ATC group had to be aggregated.

The estimated value determination itself follows specific rules. For regular purchases such as pharmaceuticals or consumables, the value is calculated typically over a 12-month period.

This requires hospitals to maintain detailed consumption records, forecast future pharmaceutical needs, and aggregate values based on clinical groupings. What appears simple in theory—adding up 12 months of pharmaceutical spending—becomes operationally complex with decentralized purchasing authority.

The consequence of miscalculation isn't merely administrative correction. If a hospital deliberately understates aggregated contract value, it commits an unlawful award without competition.

This can trigger criminal investigations under Section 256 of the Criminal Code if the fraud benefits specific suppliers. The distinction between honest accounting error and deliberate circumvention determines whether the hospital faces fines or prosecution.

microFAQ – Legal tips on calculating contract value in healthcare procurement

1. Our hospital purchased antibiotics from three different suppliers over the past year. Do we need to aggregate these purchases?
Yes, if the antibiotics belong to the same lowest-level ATC classification (active substance) or serve a unified functional purpose, they must be aggregated. The Office for the Protection of Competition considers medications with the same active substance or therapeutic category as "supplies of the same kind," even if they have different brand names, manufacturers, or purchase dates. Failure to aggregate creates exposure to ÚOHS fines and potential criminal liability. The lawyers at ARROWS Law Firm can audit your pharmaceutical procurement to identify aggregation errors before regulators do—write to office@arws.cz for a compliance review.

2. Can we split a large equipment purchase into smaller contracts to stay below the formal tender threshold?
No. If the equipment purchases form a single functional unit and occur in temporal proximity, splitting them constitutes illegal contract fragmentation under Czech law. This is one of the most actively penalized offenses, and the ÚOHS investigates such patterns aggressively. Deliberately splitting contracts to avoid competition procedures can result in contract invalidity, substantial fines (up to 10% of the contract value or CZK 20 million), and criminal referral. If you're uncertain whether your procurement structure complies with aggregation requirements, contact office@arws.cz for expert legal review.

3. What does "functional and temporal link" mean in practice?
A functional link exists when purchases serve the same purpose or form a single logical unit. Temporal proximity typically means purchases made within the same fiscal period or in close succession. For example, if your hospital purchases MRI machine maintenance services, replacement parts, and software licenses for the same equipment within a year, these are likely functionally linked and must be aggregated. The exact interpretation depends on specific facts, which is why the lawyers at ARROWS Law Firm regularly review healthcare procurement structures to identify hidden aggregation obligations.

Criminal liability for bid rigging and procurement manipulation

Healthcare procurement fraud takes many forms, but certain conduct rises to criminal level. Czech criminal law specifically criminalizes bid rigging, arranging improper advantages in contract awards, and submitting false documentation.

These aren't merely competition violations—they're criminal offenses punishable by imprisonment. The criminal statute establishes liability for anyone who intentionally gives a supplier an undue advantage at the expense of others.

This covers situations where hospital procurement staff provide confidential information to preferred suppliers or allow them to draft tender specifications. Such conduct patterns constitute criminal fraud.

Recent investigations into major Czech hospitals illustrate how serious enforcement has become. These investigations revealed patterns where preferred suppliers were allegedly involved in drafting tender specifications, allowing contracts to be tailored in their favor.

Such schemes often involve inflated pricing and subsequent kickbacks. This isn't a minor administrative failure—it is organized criminal conduct that resulted in arrests and long-term imprisonment sentences for top management.

Criminal liability extends beyond direct bribery to include all participants in the scheme. Czech law establishes parallel criminal liability for both individuals and legal entities, meaning both natural persons and corporations can be prosecuted independently.

An entity can face criminal liability even if prosecutors cannot identify which specific individual within the organization committed the crime. This creates organizational accountability: healthcare facilities themselves can face criminal prosecution.

The EPPO and Czech National Crime Agency have increasingly prioritized healthcare procurement fraud investigations, particularly those involving EU-financed projects. Ongoing enforcement patterns demonstrate that these are active prosecution priorities with dedicated resources.

Criminal liability in healthcare procurement compliance

Risks and Sanctions	How ARROWS (office@arws.cz) helps
Bid rigging and collusion with suppliers: Prison sentences up to 3-10 years (or more for organized groups), substantial monetary fines, asset forfeiture, ban from public procurement participation, and criminal record affecting ability to hold management positions. Organizations can face corporate criminal liability and substantial penalties regardless of individual culpability.	Bid rigging prevention protocols: ARROWS Law Firm designs procurement documentation, evaluation criteria, and supplier management procedures that eliminate pathways for collusion.
Procurement manipulation and contract tailoring for preferred suppliers: Criminal charges for "arranging improper advantages" (Section 256 Criminal Code), which carry imprisonment, substantial fines, contract invalidation, ÚOHS sanctions reaching 10% of contract value, and criminal record. EU investigations involve EPPO prosecution and potential cross-border enforcement.	Tender specification and evaluation design: ARROWS Law Firm creates procurement documentation that objectively defines requirements, prevents narrowing specifications to favor specific suppliers, and ensures tender criteria remain stable throughout procedures.
Failure to implement mandatory tender procedures: Contract invalidity, ÚOHS fines up to 10% of contract value, criminal investigation referral if deliberate, and requirement to repeat procurement procedures while patient care may be disrupted.	Procurement procedure selection and documentation: ARROWS Law Firm analyzes each healthcare purchase to determine applicable procedures, ensures proper aggregation of functionally linked purchases, maintains documentation demonstrating value calculations, and handles transitions between procedures.
Accepting or offering bribes in procurement: Direct imprisonment up to 5-12 years depending on circumstances and scale, monetary penalties, forfeiture of all property obtained through bribery, permanent ban from public procurement participation, criminal organization conspiracy charges, and money laundering liability.	Compliance culture and anti-corruption training: ARROWS Law Firm conducts procurement staff training on bribery recognition, develops internal policies prohibiting improper supplier relationships, establishes ethical procurement guidelines, and creates reporting mechanisms for suspected violations.
Using EU-subsidized funds in fraudulent procurement: Prosecution for damaging EU financial interests (carries 5-10 year sentences), combined with bribery and money laundering charges, asset seizure including real estate and bank accounts, reputational destruction, loss of future EU funding eligibility, and criminal conspiracy liability.	EU-funded procurement compliance: ARROWS Law Firm ensures healthcare organizations maintain separate compliance protocols for EU-financed projects, conducts audits to verify fund usage compliance, maintains documentation demonstrating transparent procedures for subsidized purchases, and represents organizations before EPPO and national prosecutors if irregularities are discovered.

Contract amendment abuse and Section 222 violations

One of the most common ways healthcare procurement creates criminal exposure is through improper contract amendments. This might seem like a technical contract management issue, but systematic amendments can trigger criminal liability.

Systematic amendments that effectively create new contracts without competitive procedures constitute violations of Section 222 of the Czech PPA. Under Section 222, substantial changes to contractual obligations that weren't reserved in the original procurement documentation are prohibited.

If a hospital purchases medical equipment through a formal tender and then uses amendments to add additional equipment or services, the amendment may constitute an unlawful contract award. The critical question is whether the amendment would have changed the competitive outcome.

To regulators, these amendments may look like circumventing competition to benefit a pre-selected supplier. If the amendment value is significant enough to have altered competitive dynamics, it can be challenged as invalid.

The Office for the Protection of Competition strictly interprets Section 222. In enforcement decisions, ÚOHS has established that even seemingly minor amendments can be considered "substantial changes" if they change the economic balance in favor of the supplier.

The maximum fine for amendment violations reaches 10% of the public contract price. More troublingly, deliberate amendment abuse to benefit specific suppliers can cross into criminal territory if it involves bribery or organized procurement manipulation.

There are limited exceptions, such as de minimis changes or necessary additional deliveries. However, this exception is narrowly construed and requires strict documentation.

Healthcare organizations must demonstrate in writing why only the original supplier can provide the additional services. Simply stating that continuity is desirable doesn't satisfy the legal standard.

For equipment deliveries, technical compatibility and necessity are key considerations. A hospital might legitimately amend a system to add compatible software that only the original vendor can provide.

The distinction requires technical and legal analysis that most hospitals don't have in-house. Moreover, when amendments involve EU-financed projects, an additional layer of regulatory scrutiny applies.

The lawyers at ARROWS Law Firm regularly advise hospitals on amendment compliance and can help structure amendments to withstand ÚOHS scrutiny. We verify whether your proposed amendment complies with Section 222 restrictions.

microFAQ – Legal tips on healthcare procurement contract amendments

1. We purchased diagnostic equipment through a formal tender, and the supplier now offers upgraded software at a modest cost. Can we amend the contract without a new tender?
This depends on several factors: whether the upgrade was clearly foreseeable at the time of original tender, whether other suppliers offer compatible upgrades, and whether the amendment triggers the thresholds set in Section 222. If the upgrade is only available from the original supplier and is technically necessary for the equipment to function as intended, an amendment might be permissible under Section 222(5)'s "necessary additional deliveries" exception (capped at 50% of value). However, the hospital must document why alternatives don't exist and why the upgrade couldn't have been included in the original tender. If you're uncertain whether your proposed amendment complies, contact the lawyers at ARROWS Law Firm at office@arws.cz for specific legal review before executing the amendment.

2. How much can we spend through a contract amendment without triggering regulatory concerns?
The de minimis rule (Section 222(4)) generally allows amendments up to 10% (supplies/services) or 15% (works) of the original value, provided they don't change the overall nature of the contract. The "necessary/unforeseeable" exceptions (Section 222(5) and (6)) allow up to 50%, but only if strict conditions are met. These are not absolute allowances; ÚOHS examines whether amendments are truly "necessary" and whether they constitute substantially new contract obligations. The lawyers at ARROWS Law Firm regularly advise hospitals on amendment compliance and can help structure amendments to withstand ÚOHS scrutiny—write to office@arws.cz.

3. We made an amendment and now we're worried about ÚOHS investigation. What should we do?
First, don't destroy or alter amendment documentation. Second, immediately contact the lawyers at ARROWS Law Firm for confidential legal review—office@arws.cz. We can assess whether your amendment violates Section 222, determine your regulatory exposure, and if necessary, arrange remedial measures (such as conducting a retroactive competitive procedure) to address violations before regulatory agencies initiate investigations.

Pharmaceutical procurement and ATC classification compliance

Healthcare procurement in the pharmaceutical field deserves specific attention because it presents unique regulatory and criminal risks. Hospitals purchase billions of crowns in pharmaceuticals annually, and this volume makes the sector particularly susceptible to corruption.

The Office for the Protection of Competition has identified pharmaceutical procurement as a high-risk area and has substantially increased enforcement activity. The complexity arises because pharmaceutical procurement operates at the intersection of three regulatory systems.

Hospitals must navigate procurement law, pharmaceutical regulation, and organized crime statutes simultaneously. Pharmaceutical products are regulated using the ATC (Anatomical Therapeutic Chemical) classification system.

Under Czech procurement law practice, medicines with the same active substance are generally considered "supplies of the same kind." Their values must be aggregated regardless of brand name, manufacturer, or formulation strength.

This classification system creates particular audit risk because it operates independently of how hospitals organize their purchasing. A hospital might have separate procurement requests from different departments, yet they must all be aggregated under the same ATC code.

If the aggregated value exceeds applicable thresholds and the hospital conducted separate purchases without formal tendering, regulatory violation occurs. Prosecutors focusing on "continuation of offense in pharmaceutical procurement" look for pattern investigation.

For hospitals with decentralized procurement authority, compliance becomes particularly challenging. Each procurement staff member must understand aggregation requirements and identify whether their proposed purchase is functionally linked to others.

When this coordination fails, violations accumulate. Excessively broad or excessively narrow pharmaceutical specifications also create criminal risk.

The ÚOHS has established that contracting authorities must use ATC codes or active substance descriptions as the primary classification tool. This means hospitals must justify every specification narrower than ATC classification with clinical evidence.

The practical consequence is that pharmaceutical procurement requires close coordination between clinical departments, pharmacy, and procurement staff. When this coordination fails, criminal exposure increases.

International elements and cross-border procurement enforcement

Healthcare procurement fraud increasingly involves international elements. EU-funded projects, cross-border supplier relationships, and coordination between European enforcement authorities have transformed procurement investigations from national to international matters.

ARROWS Law Firm regularly advises international clients and healthcare organizations with cross-border procurement relationships, understanding how EU enforcement mechanisms intersect with Czech law.

The Foreign Subsidies Regulation (Regulation (EU) 2022/2560) is directly applicable in all EU Member States, including the Czech Republic. It requires suppliers to disclose whether they've received financial support from third countries in the context of large public procurement procedures.

For international healthcare suppliers operating in the Czech market, this creates new disclosure obligations. Failure to disclose renders suppliers ineligible, and contracting authorities that award contracts to non-compliant suppliers face regulatory scrutiny.

This creates practical challenges because healthcare organizations often cannot verify supplier compliance with foreign subsidy disclosure requirements. Yet the hospital faces regulatory liability for failing to verify supplier compliance.

The European Public Prosecutor's Office prosecutes procurement crimes involving EU funds, which includes many Czech healthcare projects. EPPO investigations operate under EU law principles that can extend beyond Czech territorial jurisdiction.

For healthcare organizations with international ownership or staff, these enforcement mechanisms create particular risk. A Czech hospital subsidiary of an international group might conduct procurement following parent company policies that differ from Czech legal requirements.

These coordination failures can result in criminal investigations extending to parent company executives and international operations. ARROWS Law Firm's experience with international clients helps healthcare organizations navigate these complexities.

As a leading law firm based in Prague, European Union, our lawyers combine in-depth knowledge of Czech legal requirements with understanding of international enforcement. We help international healthcare organizations understand how their global procurement policies must adapt to Czech legal requirements.

Avoiding criminal liability: practical compliance framework

Building compliance infrastructure that prevents criminal exposure requires a systematic approach across procurement documentation, staff training, and audit procedures. This isn't a one-time compliance review—it requires ongoing commitment.

Aggregation and value determination: Healthcare organizations must establish systems ensuring that all functionally and temporally linked purchases are identified and aggregated. This requires periodic review of consumption patterns, pharmaceutical usage trends, and equipment maintenance cycles.

Specification development process: Procurement specifications must be developed through a documented process involving clinical staff, pharmacy, and procurement professionals. Documentation should demonstrate that all specifications were justified by genuine clinical or operational requirements, not by preference for specific suppliers.

Supplier management protocols: Healthcare organizations should establish policies governing supplier relationships, particularly regarding access to confidential information. Procurement staff must understand that sharing draft specifications with preferred suppliers constitutes criminal-level conduct.

Contract amendment procedures: Any proposed contract amendment should trigger formal review determining whether it violates Section 222. This review should examine whether the amendment was foreseeable, whether other suppliers could provide the goods, and whether the value exceeds thresholds.

EU funding compliance: Healthcare organizations receiving EU funds must maintain separate compliance protocols for those projects. This includes verification of supplier foreign subsidy compliance and maintenance of audit trails demonstrating competitive award processes.

Staff training and ethical culture: Procurement staff, clinical departments, and management should receive annual training on procurement legal requirements. This training should include real-world examples from prosecuted cases and clear communication that compliance is non-negotiable.

Internal audit and monitoring: Healthcare organizations should conduct periodic internal audits examining procurement procedures and contract files. These audits should specifically look for contract splitting patterns and unjustified specification narrowing.

The lawyers at ARROWS Law Firm regularly advise Czech healthcare organizations on building compliant procurement systems. We conduct compliance audits examining procurement procedures against legal requirements, identify vulnerability areas, and recommend structural changes.

Because we handle these matters on a daily basis through our Prague office serving EU healthcare sector clients, we can quickly identify compliance gaps. ARROWS Law Firm maintains professional liability insurance covering damages up to CZK 400,000,000, providing healthcare organizations with security.

Executive summary for management

Substantial criminal exposure exists in healthcare procurement: Criminal liability isn't limited to direct bribery or obvious fraud. Improper contract amendments, failure to aggregate purchases, and allowing suppliers to participate in tender development can constitute criminal offenses punishable by imprisonment.

Enforcement activity is accelerating and expanding. The European Public Prosecutor's Office and Czech National Organized Crime Agency have made healthcare procurement fraud investigation a priority. These aren't isolated cases—they reflect systematic enforcement focus.

Technical procurement errors create criminal risk: Value miscalculation, incorrect aggregation, and improper amendments appear as routine administrative matters. Yet they create vectors for criminal investigation when they benefit specific suppliers or involve bribery.

Compliance infrastructure requires expert design and ongoing monitoring. Building systems preventing criminal exposure requires understanding how European enforcement mechanisms operate and how Czech aggregation rules apply. This is substantially more complex than following internal procurement policies.

External legal expertise substantially reduces risk and liability: Healthcare organizations working with specialized legal counsel experience dramatically lower regulatory violation rates. Professional procurement compliance audits and ongoing legal monitoring cost substantially less than defending criminal investigations.

Conclusion

Healthcare procurement compliance in the Czech Republic presents extraordinary complexity because the legal requirements cross into criminal territory in ways most procurement professionals don't immediately recognize. The difference between administrative violation and criminal conduct often depends on documentation and intent.

The framework we've discussed—aggregation requirements, procurement thresholds, and criminal liability—represents the legal landscape healthcare organizations must navigate daily. Understanding each component is essential, but understanding how they interact across real purchasing decisions is where criminal exposure actually exists.

The lawyers at ARROWS Law Firm handle healthcare procurement compliance and regulatory matters constantly through our Prague office serving Czech healthcare organizations. This daily involvement allows us to identify compliance gaps, structure procurement procedures to eliminate criminal exposure, and represent organizations in regulatory proceedings.

If your healthcare organization wants to ensure it's not inadvertently creating criminal exposure, or if you've received ÚOHS inquiries, contact us. The lawyers at ARROWS Law Firm will conduct a confidential legal review and help you implement corrective measures. Write to office@arws.cz and let our specialized expertise help protect your organization.

FAQ – Frequently asked legal questions about healthcare procurement compliance in the Czech Republic

1. Our hospital received notice from ÚOHS questioning whether we properly aggregated pharmaceutical purchases across departments. What should we do immediately?
Do not destroy or alter any procurement documentation. Immediately contact the lawyers at ARROWS Law Firm at office@arws.cz. This notice likely indicates ÚOHS is reviewing your aggregation practices and may escalate to investigation if you don't respond appropriately. ARROWS Law Firm can review your purchasing records, analyze aggregation compliance, communicate with ÚOHS on your behalf, and structure remedial responses. Time is critical—ÚOHS investigations move quickly and criminal referral is possible.

2. We amended a major equipment contract without conducting a new tender procedure, and now we're concerned about Section 222 violation. Can the amendment be challenged as invalid?
Yes, it's likely vulnerable to challenge. If ÚOHS investigates, it will examine whether the amendment was foreseeable at original tender, whether you documented necessity, and whether the amendment total exceeded the allowed limits (e.g., 50% for necessary works) of the original contract value. If the amendment violated Section 222, the contract amendment itself becomes invalid, which could disrupt service delivery. More seriously, deliberate amendment to circumvent competition can trigger criminal investigation if it benefited specific suppliers through bribery or collusion. Contact ARROWS Law Firm immediately at office@arws.cz for legal assessment of your specific situation and remedial options.

3. Our international parent company handles procurement for our Czech hospital subsidiary, and their procurement policies differ from Czech legal requirements. Are we criminally liable if parent company decisions violate Czech law?
Yes. Czech criminal law holds hospitals accountable regardless of whether decisions are made locally or by parent companies. Individuals managing healthcare operations—including parent company procurement executives—can face criminal liability if their decisions violate Czech procurement requirements. This creates particular risk for international healthcare organizations because parent company policies designed for one jurisdiction may violate requirements in another. ARROWS Law Firm regularly advises international healthcare organizations on how to adapt global procurement policies to Czech legal requirements and coordinate parent company procedures with local compliance obligations. Contact office@arws.cz to discuss international procurement compliance structure.

4. We're about to implement a new pharmaceuticals procurement system and want to ensure it prevents aggregation errors. What system features should we require?
Your procurement system should require staff to identify whether each pharmaceutical purchase belongs to an ATC category for which other purchases are occurring, flag potentially aggregated purchases, and require documented justification if items aren't aggregated. The system should maintain historical consumption data enabling staff to perform aggregation analysis. It should track contract amendments and flag amendments exceeding specified value thresholds for legal review. Most importantly, the system should create audit trails documenting procurement decisions and justifications. ARROWS Law Firm can review proposed procurement system functionality to ensure it supports legal compliance. Contact office@arws.cz.

5. We discovered a potential pharmaceutical procurement violation from three years ago. Should we report it to ÚOHS, or will that expose us to criminal investigation?
This depends on specific circumstances and the nature of the violation. Generally, self-reporting violations to regulatory authorities (leniency programs exist primarily in competition law, but proactive remediation matters in criminal defense) can help mitigate penalties. However, timing, facts of the violation, and whether it involved bribery determine the strategic response. This is precisely the situation where specialized legal counsel becomes essential. Contact ARROWS Law Firm confidentially at office@arws.cz for legal assessment of whether self-reporting benefits your organization or if alternative approaches better protect your interests.

6. What documentation should healthcare procurement staff maintain to demonstrate compliance with aggregation and contract modification requirements?
Maintain written documentation showing: aggregation analysis with justification for determining purchases are/are not functionally linked; clinical justification for specification choices, including why therapeutic alternatives weren't acceptable (for pharmaceuticals); written analysis supporting each contract amendment determination that it qualifies for Section 222 exception; approval records for all procurement decisions; and supplier relationship records. Maintain these records for at least 10 years (archiving requirements vary by document type and funding source). This documentation demonstrates compliance intent and supports your position in regulatory proceedings. ARROWS Law Firm can help establish documentation protocols that simultaneously support compliance and facilitate regulatory response if investigations occur. Write to office@arws.cz.

Disclaimer: The information contained in this article is for general informational purposes only and serves as a basic guide to the issue. Although we strive for maximum accuracy in the content, legal regulations and their interpretation evolve over time. To verify the current wording of the regulations and their application to your specific situation, it is therefore necessary to contact ARROWS Law Firm directly (office@arws.cz). We accept no responsibility for any damage or complications arising from the independent use of the information in this article without our prior individual legal consultation and expert assessment. Each case requires a tailor-made solution, so please do not hesitate to contact us.